Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form

Spatially addressed combinatorial protein libraries for recombinant antibody discovery and optimization

Academic Article
uri icon
  • Overview
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • Mao, H. Y.
  • Graziano, James
  • Chase, T. M. A.
  • Bentley, C. A.
  • Bazirgan, O. A.
  • Reddy, N. P.
  • Song, Byeong Doo
  • Smider, Vaughn

publication date

  • 2010

journal

  • Nature Biotechnology  Journal

abstract

  • Antibody discovery typically uses hybridoma- or display-based selection approaches, which lack the advantages of directly screening spatially addressed compound libraries as in small-molecule discovery. Here we apply the latter strategy to antibody discovery, using a library of ?10,000 human germline antibody Fabs created by de novo DNA synthesis and automated protein expression and purification. In multiplexed screening assays, we obtained specific hits against seven of nine antigens. Using sequence-activity relationships and iterative mutagenesis, we optimized the binding affinities of two hits to the low nanomolar range. The matured Fabs showed full and partial antagonism activities in cell-based assays. Thus, protein drug leads can be discovered using surprisingly small libraries of proteins with known sequences, questioning the requirement for billions of members in an antibody discovery library. This methodology also provides sequence, expression and specificity information at the first step of the discovery process, and could enable novel antibody discovery in functional screens.
  • Antibody discovery typically uses hybridoma- or display-based selection approaches, which lack the advantages of directly screening spatially addressed compound libraries as in small-molecule discovery. Here we apply the latter strategy to antibody discovery, using a library of ∼10,000 human germline antibody Fabs created by de novo DNA synthesis and automated protein expression and purification. In multiplexed screening assays, we obtained specific hits against seven of nine antigens. Using sequence-activity relationships and iterative mutagenesis, we optimized the binding affinities of two hits to the low nanomolar range. The matured Fabs showed full and partial antagonism activities in cell-based assays. Thus, protein drug leads can be discovered using surprisingly small libraries of proteins with known sequences, questioning the requirement for billions of members in an antibody discovery library. This methodology also provides sequence, expression and specificity information at the first step of the discovery process, and could enable novel antibody discovery in functional screens.

subject areas

  • Amino Acid Sequence
  • Animals
  • Antibodies
  • Binding Sites
  • CHO Cells
  • Combinatorial Chemistry Techniques
  • Cricetinae
  • Cricetulus
  • Epitope Mapping
  • Humans
  • Immunoglobulin Fab Fragments
  • Intracellular Signaling Peptides and Proteins
  • Luminescent Measurements
  • Membrane Proteins
  • Molecular Sequence Data
  • Peptide Library
  • Protein Structure, Tertiary
  • Recombinant Proteins
  • Structure-Activity Relationship
scroll to property group menus

Identity

International Standard Serial Number (ISSN)

  • 1087-0156

Digital Object Identifier (DOI)

  • 10.1038/nbt.1694

PubMed ID

  • 20972421
scroll to property group menus

Additional Document Info

start page

  • 1195

end page

  • 1202

volume

  • 28

issue

  • 11

©2019 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support